Medicamen Biotech Performance
- Today's Low
- ₹227
- Today's High
- ₹233
- 52 Week Low
- ₹217
- 52 Week High
- ₹448
- Open Price₹227
- Previous Close₹229
- Volume3,534
- 50 DMA₹255.02
- 100 DMA₹277.65
- 200 DMA₹314.74
Medicamen Biotech Chart
Investment Returns
- Over 1 Month -14.77%
- Over 3 Month -5.08%
- Over 6 Month -40.01%
- Over 1 Year -42.51%
Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!
Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.7
- PEG Ratio
- 0.9
- Market Cap Cr
- 312
- P/B Ratio
- 1.1
- Average True Range
- 13.99
- EPS
- 7.11
- Dividend Yield
- 0.4
- MACD Signal
- -9.92
- RSI
- 41.79
- MFI
- 44.66
Latest Stock News Updates
Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.
- Business Standard
- 1 year 2 months ago
Medicamen Biotech filed its first Abbreviated New Drug Application in eCTD format for BORTEZOMIB FOR injection 3.5 MG/VIAL' with the US Food and Drug Administration
- Business Line
- 2 years 11 months ago
Medicamen Biotech Financials
Medicamen Biotech Technicals
EMA & SMA
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹239.90
- 50 Day
- ₹255.00
- 100 Day
- ₹277.60
- 200 Day
- ₹314.70
Resistance and Support
- R3 260.50
- R2 253.20
- R1 241.30
- S1 222.10
- S2 214.80
- S3 202.90
Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends
About Medicamen Biotech
- NSE Symbol
- MEDICAMEQ
- BSE Symbol
- 531146
- ISIN
- INE646B01010
Similar Stocks to Medicamen Biotech
Popular Stocks
Medicamen Biotech FAQs
Medicamen Biotech share price is ₹229 As on 25 June, 2026 | 09:49
The Market Cap of Medicamen Biotech is ₹311.6 Cr As on 25 June, 2026 | 09:49
The P/E ratio of Medicamen Biotech is 28.7 As on 25 June, 2026 | 09:49
The PB ratio of Medicamen Biotech is 1.1 As on 25 June, 2026 | 09:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.